These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Long-term follow up for anti-HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules. Ntokou IS; Iniotaki AG; Kontou EN; Darema MN; Apostolaki MD; Kostakis AG; Boletis JN Transpl Int; 2011 Nov; 24(11):1084-93. PubMed ID: 21848902 [TBL] [Abstract][Full Text] [Related]
24. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts. Lachmann N; Terasaki PI; Budde K; Liefeldt L; Kahl A; Reinke P; Pratschke J; Rudolph B; Schmidt D; Salama A; Schönemann C Transplantation; 2009 May; 87(10):1505-13. PubMed ID: 19461487 [TBL] [Abstract][Full Text] [Related]
25. Early findings of prospective anti-HLA donor specific antibodies monitoring study in pancreas transplantation: Indiana University Health Experience. Mujtaba MA; Fridell JA; Higgins N; Sharfuddin AA; Yaqub MS; Kandula P; Chen J; Mishler DP; Lobashevsky A; Book B; Powelson J; Taber TE Clin Transplant; 2012; 26(5):E492-9. PubMed ID: 22938159 [TBL] [Abstract][Full Text] [Related]
26. The presence of donor-specific antibodies in renal transplantation. Tozkir H; Sağiroğlu T; Kiliçarslan-Ayna T; Tan S; Çopuroğlu E; Sağiroğlu G; Sari G; Gürkan H; Sezer A Transplant Proc; 2012; 44(6):1667-9. PubMed ID: 22841240 [TBL] [Abstract][Full Text] [Related]
27. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts. Lawrence C; Willicombe M; Brookes PA; Santos-Nunez E; Bajaj R; Cook T; Roufosse C; Taube D; Warrens AN Transplantation; 2013 Jan; 95(2):341-6. PubMed ID: 23197178 [TBL] [Abstract][Full Text] [Related]
28. Effects of Two Preemptive Post-transplant Desensitization Regimens Upon Renal Allograft Survival and DSA Elaboration. Kimball PM; McDougan FA; King A Clin Transpl; 2014; ():197-203. PubMed ID: 26281145 [TBL] [Abstract][Full Text] [Related]
29. Evolution of donor-specific antibodies (DSA) and incidence of de novo DSA in solid organ transplant recipients after switch to everolimus alone or associated with low dose of calcineurin inhibitors. Perbos E; Juinier E; Guidicelli G; Dromer C; Merville P; Billes MA; Taupin JL; Neau-Cransac M Clin Transplant; 2014 Sep; 28(9):1054-60. PubMed ID: 25040585 [TBL] [Abstract][Full Text] [Related]
30. Donor-specific HLA antibodies in paediatric cardiac transplant recipients are associated with poor graft survival. Irving C; Carter V; Parry G; Hasan A; Kirk R Pediatr Transplant; 2011 Mar; 15(2):193-7. PubMed ID: 21199210 [TBL] [Abstract][Full Text] [Related]
31. Detailed examination of HLA antibody development on renal allograft failure and function. Zhu L; Lee PC; Everly MJ; Terasaki PI Clin Transpl; 2008; ():171-87. PubMed ID: 19711514 [TBL] [Abstract][Full Text] [Related]
32. Early Intervention in Living Kidney Transplantation Based on Dynamic Monitoring of Donor Specific Antibodies. Chen Y; Li LY; Lou XY; Wang H; Zhang L; Zhu YH Clin Transpl; 2014; ():205-8. PubMed ID: 26281146 [TBL] [Abstract][Full Text] [Related]
33. Role of human leukocyte antigen, donor-specific antibodies, and their impact in renal transplantation. Thiyagarajan UM; Bagul A; Frost J; Horsburgh T; Nicholson ML Transplant Proc; 2012 Jun; 44(5):1231-5. PubMed ID: 22663991 [TBL] [Abstract][Full Text] [Related]
34. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance. Waki K; Sugawara Y; Mizuta K; Fujita H; Kadowaki T; Kokudo N Clin Transpl; 2011; ():223-35. PubMed ID: 22755416 [TBL] [Abstract][Full Text] [Related]
35. High immunologic risk living donor kidney transplant using bortezomib in a novel induction regimen without acute antibody mediated rejection. Dunn TB; Borja-Cacho D; Chinnakotla S; Finger E; Tamayo G; Verghese P; Kim Y; Manivel C; Kandaswamy R; Matas A; Pruett T; Noreen H; Krefting P; Maurer D Clin Transpl; 2011; ():381-7. PubMed ID: 22755435 [TBL] [Abstract][Full Text] [Related]
36. The Role of Donor-Specific Antibodies in Intestinal Transplantation: Experience at the University of California Los Angeles and Literature Review. Cheng EY; Kaneku H; Farmer DG Clin Transpl; 2014; ():153-9. PubMed ID: 26281140 [TBL] [Abstract][Full Text] [Related]
37. Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis. Klein K; Süsal C; Schäfer SM; Becker LE; Beimler J; Schwenger V; Zeier M; Schemmer P; Macher-Goeppinger S; Scherer S; Opelz G; Morath C Atheroscler Suppl; 2013 Jan; 14(1):199-202. PubMed ID: 23357165 [TBL] [Abstract][Full Text] [Related]
38. Combination of Total Lymphoid Irradiation, Low-Dose IVIG and ATG as Rescue Therapy for Highly Sensitized and Antibody-Mediated Rejection Renal Transplant Recipients. Zhu D; Qi G; Tang Q; Li L; Yang C; Lin M; Wu B; Xu M; Cai J; Zhu T; Rong R Clin Transpl; 2014; ():215-21. PubMed ID: 26281148 [TBL] [Abstract][Full Text] [Related]
39. Kidney transplantation in the US: an analysis of the OPTN/UNOS registry. Freitas MC Clin Transpl; 2011; ():1-16. PubMed ID: 22755397 [TBL] [Abstract][Full Text] [Related]